RMR Wealth Builders - LA JOLLA PHARMACEUTICAL CO ownership

LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 78 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q1 2021. The put-call ratio across all filers is 2.29 and the average weighting 1.3%.

Quarter-by-quarter ownership
RMR Wealth Builders ownership history of LA JOLLA PHARMACEUTICAL CO
ValueSharesWeighting
Q1 2021$34,000
-5.6%
8,000
-14.9%
0.01%
-50.0%
Q4 2020$36,000
-58.1%
9,400
-56.1%
0.02%
-18.2%
Q3 2020$86,000
+100.0%
21,431
+112.2%
0.02%
-42.1%
Q2 2020$43,000
+38.7%
10,100
+29.5%
0.04%
+26.7%
Q4 2019$31,0007,8000.03%
Other shareholders
LA JOLLA PHARMACEUTICAL CO shareholders Q1 2021
NameSharesValueWeighting ↓
TANG KEVIN C 240,000$1,027,00095.09%
TANG CAPITAL MANAGEMENT LLC 10,049,224$43,011,0008.56%
RTW INVESTMENTS, LP 2,327,903$9,963,0000.15%
Boxer Capital, LLC 890,700$3,812,0000.13%
Tibra Equities Europe Ltd 72,600$311,0000.10%
WealthTrust Axiom LLC 25,400$108,0000.04%
GSA CAPITAL PARTNERS LLP 52,749$226,0000.02%
FIRST MIDWEST BANK TRUST DIVISION 34,231$147,0000.02%
HOLLENCREST CAPITAL MANAGEMENT 42,355$181,0000.02%
Summit Global Investments 48,500$208,0000.01%
View complete list of LA JOLLA PHARMACEUTICAL CO shareholders